Are Dermatology Prior Authorization Delays Slowing Down Reimbursements in 2026?
Yes, dermatology prior authorization delays are increasingly slowing down reimbursements in 2026 as payers expand utilization review policies for high-cost dermatologic treatments and procedures. Many dermatology practices are experiencing longer approval timelines, stricter documentation requirements, and higher administrative workloads before services can even be billed. Prior authorizations are designed to ensure medical necessity, but in dermatology—where biologics, specialty medications, and advanced treatments are common—the process has become more complex. As a result, delays at the authorization stage are now one of the leading contributors to reimbursement slowdowns. Why Prior Authorizations Are Increasing in Dermatology Several industry changes are contributing to the rise in dermatology prior authorization delays . Payers are expanding review requirements for treatments that involve: Biologic therapies for psoriasis and eczema Advanced dermatologic procedures High-...